SIGMAR1 and mild neurocognitive disorder: The results of this study show that two novel Sig-1R ligands, coded as EST79232 and EST79376, exert neuroprotective effects in three different experimental models of MN degeneration, hence adding to previous studies highlighting Sig-1R as a promising target to treat MND.